Unveiling the Cognitive Benefits of GLP-1 Agonists in Diabetes and Obesity
Unveiling the Cognitive Benefits of GLP-1Agonists in Diabetes and Obesity Lotus Clinical Research is proud to be featured in an exciting study in collaboration with Evolution Research Group and Gonzaba Medical Group, exploring the cognitive effects of GLP-1 agonists in patients with type 2 diabetes and obesity. This study aims to uncover potential neuroprotective benefits … Read more